Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination

Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination

US Patent 10526590 · Granted Jan 7, 2020

Estimated economic value: $62,708,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sequencing methods with partitioning2025
Methods and systems for analyzing nucleic acid molecules2025
Methods and systems for analyzing nucleic acid molecules2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
Methods and systems for analyzing nucleic acid molecules2025
Compositions and methods for analyzing DNA using partitioning and base conversio2025
Methods and systems for analyzing nucleic acid molecules2024
Methods and systems to improve the signal to noise ratio of DNA methylation part2024
Methods for making novel antigen binding domains2023
Combination therapy with gold controlled transgenes2023
Compositions and methods for isolating cell-free DNA2023
Gold optimized CAR t-cells2023